Testing a new eye ointment for dry eyes (Vit-A-Vision)
Part of Brain & nervous system, Eyes & vision, Injuries & trauma clinical trials.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have dry eye symptoms with an OSDI score of 16 or higher (moderate to severe).
- Your tear film break-up time must be 10 seconds or less in at least one eye (meaning your tears evaporate quickly).
- You must be willing to use the study ointment daily for about 33 days.
- You must be able to attend follow-up visits at day 15 and day 33.
- You must stop using contact lenses during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This study tests a new eye drop solution (PRO-240) compared to an existing one (Optive) in healthy adults. It aims to see how safe and comfortable the new drops are for dry eye relief.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.
This study tests a new lubricating eye drop designed to relieve dry eye symptoms. If you have dry eye disease, this trial may help determine if the new formula works better than what's currently available.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
Hear when a new Burning Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.